Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 28, 1996 - Issue 2
Submit an article Journal homepage
39
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Antibody Response and Reactions to Completion of a Four-dose Series with a Two - or Three-component Acellular Pertussis Vaccine Compared to Whole Cell Pertussis Vaccine

Michael E. Pichichero Department of Microbiology, Immunology, University of Rochester Medical Center, Elmwood Pediatric Group, Rochester, New York
,
John L. Green Department of Microbiology, Immunology, University of Rochester Medical Center, Elmwood Pediatric Group, Rochester, New York
,
Anne B. Francis Department of Microbiology, Immunology, University of Rochester Medical Center, Elmwood Pediatric Group, Rochester, New York
,
Steven M. Marsocci Department of Microbiology, Immunology, University of Rochester Medical Center, Elmwood Pediatric Group, Rochester, New York
,
A. Marie Lynd Murphy Department of Microbiology, Immunology, University of Rochester Medical Center, Elmwood Pediatric Group, Rochester, New York
&
Charles Buscarino SmithKline Beecham Research Laboratories, Philadelphia, Pennsylvania, USA
Pages 159-163 | Received 09 Jun 1995, Accepted 14 Dec 1995, Published online: 08 Jul 2009

References

  • Kimura M, Kuno-Sakai H. Developments in pertussis immunization in Japan. Lancet 1990; 336: 30–32
  • Marwick C. Acellular pertussis vaccine hailed for infants. JAMA 1995; 274: 446–447
  • Pichichero M E, Francis A B, Marsocci S M, Green J L, Disney F A. Comparison of a diphtheria and tetanus toxoids and bicomponent acellular pertussis vaccine with diphtheria and tetanus toxoids and whole-cell pertussis vaccine in infants. Am J Dis Child 1993; 147: 295–299
  • Pichichero M E, Green J L, Francis A B, Marsocci S M, Lynd M, Litteer T. Comparison of a 3-component acellular pertussis vaccine with whole cell pertussis vaccine in 2-morth-old children. Pediatr Infect Dis J 1994; 13: 193–196
  • Report of the Committee on Infectious Diseases, 22nd Edition, G Peter. American Academy of Pediatrics, Elk Grove Village, IL 1994; 7–32
  • Pichichero M E, Christy C, Decker M D, Meade B D, Steinhoff M C, Edwards K M, Rennels M B, Anderson E L, Englund J A. Defining the key parameters for comparing reactions among acellular and whole-cell DTP vaccines. Pediatrics 1995; 96(S)588–592
  • Edwards K M, Meade B D, Decker M D, Reed G F, Rennels M B, Steinhoff M C, Anderson E L, Englund A J, Pichichero M E, Deloria M A, Deforest A. Comparison of 13 acellular pertussis vaccines: Overview and serologic response. Pediatrics 1995; 96(S)548–556
  • Decker M D, Edwards K M, Steinhoff M C, Rennels M B, Pichichero M E, Englund J A, Anderson E A, Deloria M A, Reed G F. Comparison of 13 acellular pertussis vaccines: Adverse reactions. Pediatrics 1995; 96(S)557–566
  • Kanra G, Ceyhan M, Vandevoorde D, Bogaerts H. Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children. Eur J Pediatr 1993; 152: 473–483
  • Bernstein H H, Rothstein E P, Pennridge Pediatric Associates. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants. Pediatrics 1994; 93: 656–659
  • Annunziato P W, Rothstein E P, Bernstein H H, Blatter M M, Reisinger K S, Pichichero M E. Comparison of a 3-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 4- through 6-year-old children. Arch Pediatr Adolesc Med 1994; 148: 503–507
  • Barkin R M, Pichichero M E. Diphtheria-pertussis-tetanus vaccine: reactogenicity of commercial products. Pediatrics 1979; 63: 256–260
  • Cody C L, Baraff L J, Cherry J D, Marcy S M, Manclark C R. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 1981; 68: 650–660
  • Englund J A, Decker M D, Edwards K M, Pichichero M E, Steinhoff M C, Anderson E L. Acellular and whole-cell pertussis vaccines as booster doses: a multicenter study. Pediatrics 1994; 93: 37–43
  • Halperin S A, Mills E, Barreto L, Pim C, Eastwood B J. Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age. Pediatr Infect Dis J 1995; 14: 792–797

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.